AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CAL

Caleres Inc. Common Stock (CAL) fair value

Consumer Cyclical · Apparel Retail · NYSE · United States
$12.95-3.00%
Market cap $447MNext earnings 2026-12-08Updated Oct 21, 2026
Add earnings to calendarGoogle
Our verdict
Trades 219% above our fair value
Price
$12.95
Model fair valueConfidence: medium
$4.06
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, and Discounted cash flow.
ACCE opinionCaleres Inc. Common Stock (CAL)
Fair value (3 models)
Not available
ACCE price target
$12.80
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $12.95 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
66
out of 100
Analysts
50% buy
2 covering
P/E
8.5x
forward 5.9x
1-year return
+1.0%
Dividend yield
2.10%

Caleres Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Caleres sells footwear through its Famous Footwear discount chain and its Allen Edmonds and Vionic brands, with a wholesale business supplying shoes to third-party retailers. At 8.6 times trailing earnings and 7.7 times forward, the stock is priced for a business that is not expected to grow much, yet revenue is still rising 5.6% and gross margin holds near 45%. The thin 3.4% operating margin is the weak point: most of that gross profit is consumed by store and overhead costs, so small swings in sales or markdowns move earnings a lot. That makes the investment case hinge on whether Vionic and the premium brands can keep lifting mix and cost discipline without a consumer slowdown undoing it, which is worth checking in the most recent quarterly margin trend before going further.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • moderate
    Leverage elevated
    Debt/Equity of 1.48 is high for a company with a 3.4% operating margin and 1.8% net margin, leaving little cushion if sales soften.
  • moderate
    Quality score weak
    Quality sub-score is 47/100 against a Value sub-score of 96, so the cheap multiple reflects thin profitability more than durable economics.
  • moderate
    Heavy short interest
    Short interest stands at 12.0% of ownership, which signals meaningful bearish positioning and can amplify volatility around earnings.

AI research notes

AI-assisted·How I use AIWritten Oct 14, 2026 · figures from 2026-07-31 · prices to Oct 23, 2026
Why it could do well
  • Shares trade at 7.7x forward earnings against a sector median of 17.5x, a steep discount for the group.
  • The latest quarter beat expectations, with earnings per share of 0.47 against 0.37 expected, a 27.0% surprise.
  • Free cash flow yields 7.8%, and the company has cut its diluted share count by 2.6% in the last fiscal year.
Why it could disappoint
  • Return on invested capital is negative at -0.4%, so the business is not currently earning back what it spends.
  • Debt is 1.48 times equity, and a net margin of 1.8% leaves little room to absorb a downturn in sales.
  • Only 1 of 2 analysts rates the stock Buy or Strong Buy, and revenue growth of 5.6% trails the 5-year average of 5.4% only slightly.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Dec 8, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CAL's valuation models land
Price
$12.95
Model fair valueConfidence: medium
$4.06
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed50% buy · 2 covering analysts
● Strong buy 1● Buy 0● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-0.2%
1 month
+4.8%
3 months
+9.9%
6 months
-4.4%
YTD
+6.4%
1 year
+1.0%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$12.80first publication$12.30
12 Oct 2026, 00:00 CESTFair value$15.09$12.93$12.09
8 Oct 2026, 00:00 CESTFair value$12.93$12.78$12.46
1 Oct 2026, 00:00 CESTFair value$12.78$13.00$12.45
26 Sept 2026, 00:00 CESTFair value$13.00$13.40$12.49
24 Sept 2026, 00:00 CESTFair value$13.40$12.76$12.79
21 Sept 2026, 00:00 CESTFair value$12.76$12.93$11.74
19 Sept 2026, 00:00 CESTFair value$12.93$13.08$12.08
14 Sept 2026, 00:00 CESTFair value$13.08$16.23$12.51
12 Sept 2026, 00:00 CESTFair value$16.23$13.44$11.88

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CAL page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value96Quality47Momentum56Total66
Valuation
Trailing P/E
8.5x
Forward P/E
5.9x
PEG
0.01
P/B
0.63x
EV / Revenue
0.4x
Book value/sh
$19.52
Enterprise value
$1.3B
Profitability
ROE
7.7%
FCF yield
7.37%
ROIC
-0.4%
Health and risk
Debt / equity
1.48
Dividend yield
2.10%
Beta
0.74

Price

+3.0% · 1Y

Ask anything about CAL

Answered from Caleres Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 8.5x8.5xhigh 54.1x
ROEbetter than 33% of peers
low -6%8%high 27%
Div yieldbetter than 83% of peers
low 0.0%2.1%high 2.8%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CAL Caleres Inc. Common Stock$12.95--8.5x7.7%4766
FORUS.SN Forus S.ACLP 1681.90--18.2x9.2%6446
GCO Genesco Inc. Common Stock$37.39$349% above9.6x7.8%4263
CTRN Citi Trends Inc. Common Stock$46.00$2585% above54.1x6.2%3347
RVRC.ST RVRC Holding AB (publ)kr 54.15kr 563% below17.5x26.8%9359
SFIX Stitch Fix Inc. Class A Common Stock$2.72----6.3%3930
JILL J. Jill Inc. Common Stock$22.85$245% below12.6x20.8%6076

Sector report card

Where CAL ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Sep 9, 2026
    Caleres Reports Second Quarter 2026 Results
  • Business Wire•Sep 1, 2026
    Caleres to Announce Second Quarter 2026 Results on September 9
  • Business Wire•Aug 28, 2026
    Caleres Declares Regular Quarterly Dividend
2 more press releases · full archive on Investor+.INVESTOR
40 filings
September 2026
Sep 15
Form 4Insider transactionPeriod 2026-09-11
View on SEC →
Sep 15
Form 4Insider transactionPeriod 2026-09-11
View on SEC →
Sep 15
Form 4Insider transactionPeriod 2026-09-11
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR